You Searched For "Bharat Biotech"

WHO approves Hyd based Bharat Biotechs Covaxin for Emergency Use Listing
WHO approves Hyd based Bharat Biotech's Covaxin for Emergency Use Listing

The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and...

By Newsmeter Network  Published on 3 Nov 2021 11:59 AM GMT


Australia adds Bharat Biotechs Covaxin to list of recognized vaccines
Australia adds Bharat Biotech's Covaxin to list of 'recognized' vaccines

The TGA of the ministry of health of the Australian government, in a statement, said, “Covaxin would be ‘recognized’ for the purpose of establishing a...

By Newsmeter Network  Published on 1 Nov 2021 10:44 AM GMT


Need additional clarifications on `Covaxin before EUL: WHO to Hyd-based Bharat Biotech
Need additional clarifications on `Covaxin' before EUL: WHO to Hyd-based Bharat Biotech

The technical advisory group will now meet on November 3 for a final risk-benefit assessment.

By Newsmeter Network  Published on 27 Oct 2021 2:49 AM GMT


Phase 2/3 trials of `Covaxin for use in children completed:  Bharat Biotech MD
Phase 2/3 trials of `Covaxin' for use in children completed: Bharat Biotech MD

The company is expected to submit the data by next week to the DCGI, chairman and managing director of Bharat Biotech International Ltd Krishna Ella...

By Newsmeter Network  Published on 22 Sep 2021 4:11 AM GMT


Bharat Biotech releases first commercial batch of Covaxin from its Ankleshwar plant
Bharat Biotech releases first commercial batch of Covaxin from its Ankleshwar plant

The Union minister for health and family welfare, Mansukh Mandaviya, released the first commercial batch of Covaxin from Bharat Biotech’s Chiron...

By Newsmeter Network  Published on 29 Aug 2021 8:31 AM GMT


Hyderabad: IVI, Bharat Biotech launch phase II trial of Chikungunya vaccine in Costa Rica
Hyderabad: IVI, Bharat Biotech launch phase II trial of Chikungunya vaccine in Costa Rica

International Vaccine Institute (IVI) on Wednesday said Bharat Biotech's Chikungunya vaccine candidate (BBV87) was administered to first volunteer in...

By Newsmeter Network  Published on 25 Aug 2021 8:16 AM GMT


Hyd-based Bharat Biotechs nasal vaccine gets approval for phase II-III trials
Hyd-based Bharat Biotech's nasal vaccine gets approval for phase II-III trials

Bharat Biotech's intranasal vaccine has received regulatory approval for phase II and III trials. This is a first-of-its-kind COVID-19 jab to undergo...

By Newsmeter Network  Published on 13 Aug 2021 1:31 PM GMT


Hyd-based Bharat Biotechs rotavirus vaccine Rotovac 5D gets WHO pre-qualification
Hyd-based Bharat Biotech's rotavirus vaccine 'Rotovac 5D' gets WHO pre-qualification

Hyderabad: Bharat Biotech on Monday announced that the World Health Organization (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac...

By Newsmeter Network  Published on 2 Aug 2021 2:30 PM GMT


Hyderabad-based Bharat Biotechs Covaxin effective against Delta Plus: ICMR
Hyderabad-based Bharat Biotech's Covaxin effective against Delta Plus: ICMR

A study by the Indian Council of Medical Research (ICMR) said that Covaxin, India's first indigenous vaccine to fight COVID-19, is effective against...

By Newsmeter Network  Published on 2 Aug 2021 11:05 AM GMT


5% royalty from Covaxins net sales will go to ICMR: Centre
5% royalty from Covaxin's net sales will go to ICMR: Centre

The ministry of health and family welfare on Tuesday said the Indian Council of Medical Research (ICMR) will get five per cent royalty from the net...

By Newsmeter Network  Published on 28 July 2021 2:25 AM GMT


`Covaxin overall 77.8% effective: Here are Bharat Biotechs Phase III trial results
`Covaxin' overall 77.8% effective': Here are Bharat Biotech's Phase III trial results

Efficacy data demonstrates 63.6 percent protection against asymptomatic COVID-19 and efficacy data demonstrates 65.2 percent protection against the...

By Newsmeter Network  Published on 3 July 2021 4:14 AM GMT


Covaxin phase III clinical trials show 77.8% efficacy
Covaxin phase III clinical trials show 77.8% efficacy

The phase III clinical trials of Bharat Biotech’s Covaxin showed 77.8 per cent efficacy, said media reports on Tuesday citing sources.

By Newsmeter Network  Published on 22 Jun 2021 12:30 PM GMT


Share it